Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | LIPE | Q05469 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5647911 | 0.87 | LIPE (0.50) | RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A | |
| SCHEMBL5649336 | 0.87 | HRH3 (0.54) | LTA4HRAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL5646729 | 0.87 | RAB9A (0.53) | RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A | |
| SCHEMBL5649346 | 0.85 | CYP1A2 (0.51) | LTA4HRAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL5649029 | 0.85 | RAB9A (0.51) | RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A | |
| SCHEMBL5648985 | 0.84 | RAB9A (0.65) | RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A | |
| SCHEMBL5649047 | 0.84 | CYP2D6 (0.52) | RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A | |
| SCHEMBL5650067 | 0.82 | RAB9A (0.59) | RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A | |
| SCHEMBL5646668 | 0.79 | RAB9A (0.66) | LTA4HRAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL5652249 | 0.79 | RAB9A (0.62) | RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060148860-A1 | Substituted p-phenyl carbamates | NOVO NORDISK A/S (DK) | 2006-07-06 | — | — | US | claimed |
| EP-1636188-A1 | PARA-SUBSTITUTED PHENYL CARBAMATES AS INHIBITORS OF HORMONE SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2006-03-22 | — | — | EP | claimed |
| WO-2004111006-A1 | PARA-SUBTITUTED PHENYL CARBAMATES AS INHIBITORS OF HORMONE SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2004-12-23 | — | — | WO | claimed |
| US-20060148860-A1 | Substituted p-phenyl carbamates | NOVO NORDISK A/S (DK) | 2006-07-06 | — | — | US | disclosed |
| EP-1636188-A1 | PARA-SUBSTITUTED PHENYL CARBAMATES AS INHIBITORS OF HORMONE SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004111006-A1 | PARA-SUBTITUTED PHENYL CARBAMATES AS INHIBITORS OF HORMONE SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2004-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148860-A1 | Substituted p-phenyl carbamates | LIPE, PNLIP, LPL | LTA4H 481/4885RAB9A 1647/4885SMN1; SMN2 2599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.